ConductScience.org, home

Paper500658

Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.

Nelson DJ and 8 others. J Biol Chem, 1979. Cited by 114 papers, by iCite.

Cite this record

ConductScience Library. Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation. Papers, record 500658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/500658

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.
PubMed
Journal
J Biol Chem
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
114
iCite
Relative citation ratio, by iCite
4.36
iCite
Revised in PubMed
2026-01-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nelson DJD J
2LaFon SWS W
3Tuttle JVJ V
4Miller WHW H
5Miller RLR L
6Krenitsky TAT A
7Elion GBG B
8Berens RLR L
9Marr JJJ J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AllopurinolMajor topic
AnthelminticsMajor topic
LeishmaniaMajor topic
RibonucleosidesMajor topic
Animals
Dose-Response Relationship, Drug
Kinetics
Phosphorylation

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.

PMIDTitleJournalYearIn PapersSource
40628941Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis.Commun Biol2025https://conductscience.org/library/papers/40628941PubMed
37835666High Performance Liquid Chromatography Analysis and Description of Purine Content of Diets Suitable for Dogs with Leishmania Infection during Allopurinol Treatment-A Pilot Trial.Animals (Basel)2023https://conductscience.org/library/papers/37835666PubMed
36355877An Overview on Leishmaniasis in Romania: Diagnosis and Therapeutics.Trop Med Infect Dis2022https://conductscience.org/library/papers/36355877PubMed
27606425Characterization of a Novel Endoplasmic Reticulum Protein Involved in Tubercidin Resistance in Leishmania major.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/27606425PubMed
26334763A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/26334763PubMed
24277328Pyrazolopyrimidine metabolism in parasitic protozoa.Pharm Res1984https://conductscience.org/library/papers/24277328PubMed
24272839Inosine analogs as anti-leishmanial agents.Pharm Res1985https://conductscience.org/library/papers/24272839PubMed
17851411Symmetrically and unsymmetrically bridged methylenebis(allopurinols): synthesis of dimeric potential anti-gout drugs.Molecules2007https://conductscience.org/library/papers/17851411PubMed
16418526Drug resistance in leishmaniasis.Clin Microbiol Rev2006https://conductscience.org/library/papers/16418526PubMed
16127040Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16127040PubMed
8517715Effects of probenecid on the pharmacokinetics of allopurinol riboside.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8517715PubMed
8335625Purine metabolism by intracellular Chlamydia psittaci.J Bacteriol1993https://conductscience.org/library/papers/8335625PubMed
8335624Pyrimidine metabolism by intracellular Chlamydia psittaci.J Bacteriol1993https://conductscience.org/library/papers/8335624PubMed
74796553'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo.Parasitol Res1995https://conductscience.org/library/papers/7479655PubMed
6982678Comparative effects of 4-aminopyrazolopyrimidine, its 2'-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6982678PubMed
6835838A convenient synthesis of 6-amino-1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidin-4-one and related 4,6-disubstituted pyrazolopyrimidine nucleosides.Nucleic Acids Res1983https://conductscience.org/library/papers/6835838PubMed
6817705Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6817705PubMed
6712205Biological action of inosine analogs in Leishmania and Trypanosoma spp.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6712205PubMed
6605408Purine salvage networks in Giardia lamblia.J Exp Med1983https://conductscience.org/library/papers/6605408PubMed
6573672Pyrimidine metabolism in Tritrichomonas foetus.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6573672PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/500658

GET https://conductscience.org/api/papers/v1/500658/cited_by?page=2